Last reviewed · How we verify
NCT06711237
Resin-Cement Type Influence on Cement Remnants in Implant-Supported Restorations
NA trial testing self-adhesive resin cement (RC) in Dental Cements in 30 participants. Completed in 1 September 2022.
1 March 2022
Quick facts
| Lead sponsor | Vilniaus Implantologijos Centro (VIC) Klinika |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | non randomized |
| Design | sequential |
| Masking | single |
| Primary purpose | treatment |
| Enrollment | 30 |
| Start date | 1 September 2021 |
| Primary completion | 1 March 2022 |
| Estimated completion | 1 September 2022 |
| Sites | 1 location across Lithuania |
Drugs / interventions tested
- self-adhesive resin cement (RC)
- resin-modified glass-ionomer cement (RMGIC)
Conditions studied
- Dental Cements — all drugs for Dental Cements →
Sponsor
Vilniaus Implantologijos Centro (VIC) Klinika
Who can join
Eligibility, any sex, with Dental Cements. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
This study quantitatively compared cement residues of two resin cement types around implant-supported restorations (ISR) with a crown-abutment margin located at the gingival level. This prospective, single-blinded, cross-over clinical trial compared optically detectable cement remnants between Self-Adhesive Resin Cement (RC) and Resin-Modified Glass Ionomer Cement (RMGIC).
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06711237
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other Vilniaus Implantologijos Centro (VIC) Klinika trials
Trials by the same sponsor.
- NCT06708247 — Reconstructive Therapy for Peri-implantitis Using Tuberosity Bone with or Without Electrolytic Cleaning: a Randomized Cl · NA · completed
- NCT04737525 — Connective Tissue Graft Versus a Porcine-derived Membrane (Mucoderm) After Immediate Placement · NA · active not recruiting
- NCT04653025 — Immedaite vs Early Implant Placement in Aesthetic Area · NA · active not recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06711237 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Vilniaus Implantologijos Centro (VIC) Klinika
- Last refreshed: 2 December 2024
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06711237.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing